Работы, цитирующие эту работу

Работ: 2

Работа: Residual ctDNA after treatment predicts early relapse in patients with early-stage non-small cell lung cancer

1. Prognostic value of postoperative circulating tumor DNA for recurrence-free survival in resected non-small cell lung cancer: a systematic review and meta-analysis

   Atta Ullah Khan, Intizor Avazmetova, Mukhayya Ruzieva +4

   СтатьяCancer Genomics and DiagnosticsClinical & Translational Oncology2025Цитирований: 1

   ABIABI:AkademIndex/openalex/2026.other.316167

2. Circulating tumor DNA-based detection of molecular residual disease in isocitrate dehydrogenase-mutant cholangiocarcinoma for biomarker-guided therapy

   Alexei Valerievich Yumashev, Boymuradov Shuxrat, Kasimov Khayotbek +5

   СтатьяCholangiocarcinoma and Gallbladder Cancer StudiesClinical & Translational Oncology2026Цитирований: 0

   ABIABI:AkademIndex/openalex/2026.article.009135